The need for improved identification and accurate classification of stages 3-5 chronic kidney disease in primary care: Retrospective cohort study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Jain, Poorva ^a   Calvert, Melanie ^a   Cockwell, Paul ^a,b   McManus, Richard J ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; BLOOD; COHORT ANALYSIS; DISEASE MANAGEMENT; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SERVICE; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; REGISTER; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDS; TOTAL QUALITY MANAGEMENT; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CREATININE; DISEASE MANAGEMENT; FEMALE; GLOMERULAR FILTRATION RATE; GREAT BRITAIN; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84905909011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100831     Document Type: Article

References (37)

1. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of Internal Medicine 145: 247-254. (Pubitemid 46768608)
2. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, et al (2004) Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. N Engl J Med 351: 1285-1295. doi: 10.1056/NEJMoa041365. (Pubitemid 39258422)
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305. 10.1056/NEJMoa041031 [doi];351/13/1296 [pii].
4. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, et al (2011) Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney DiseaseA Cohort Study. Annals of Internal Medicine 154: 12-21. doi: 10.1059/0003-4819-154-1-201101040-00003.
5. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B (2012) Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 27 Suppl 3: iii73-iii80. gfs269 [pii];10.1093/ndt/gfs269 [doi].
6. Collins AJ, Chen SC, Gilbertson DT, Foley RN (2009) CKD surveillance using administrative data: impact on the health care system. American Journal of Kidney Diseases 53: S27-S36. S0272-6386(08)01724-1 [pii];10.1053/j.ajkd.2008. 07.055 [doi].
7. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139: 137-147. 200307150-00013 [pii].
8. Department of Health. (2005) The National Service Framework for renal services. Pt. 2, Chronic Kidney Disease, Acute Renal Failure and End of Life Care. London: Department of Health.
9. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians of London and the Renal Association (2006) identification, management and referral of adults with chronic kidney disease. guidelines for general physicians and general practitioners. JAMA.
10. NHS Information Centre (2010) Quality and Outcomes Framework Achievement Data 2009/10. Kidney Int.
11. de Lusignan S, Tomson C, Harris K, Van VJ, Gallagher H (2011) Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clinical Practice 117: c213-c224. 000320341 [pii];10.1159/000320341 [doi].
12. Mackenzie F. (2011) Notes from Birmingham Quality, UK NEQAS, February 2010.
13. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N (2009) Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 338.
14. Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, et al (2006) Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf 15: 861-872. (Pubitemid 44941639)
15. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P (2008) Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 94: 34-39.
16. NHS Primary Care Commissioning (2009) QOF Implementation: Business Rules. BMJ.
17. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N (2009) Evaluation of the management of heart failure in primary care. Family Practice 26: 145.
18. 2013) Chapter 1: Definition and classification of CKD. Kidney Int Suppl 3: 19-62.
19. Office for National Statistics (2004) Census 2001: National report for England and Wales.
20. Stevens PE, O'Donoghue DJ, de Lusignan S, Van VJ, Klebe B, et al (2007) Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 72: 92-99. 5002273 [pii];10.1038/sj.ki.5002273 [doi].
21. Aresu M, Chaudhury M, Diment E, Fuller E, Gordon-Dseagu V, et al (2010) Health Survey of England 2009.
22. Office for National Statistics (2012) All releases of Population Estimates for UK, England and Wales, Scotland and Northern Ireland.
23. Akaike H (1981) Likelihood of a model and information criteria. Journal of Econometrics 16: 3-14.
24. Blundell R, Windmeijer F (1997) Cluster effects and simultaneity in multilevel models. Health Econ 6: 439-443. 10.1002/(SICI)1099-1050(199707)6: 4〈439::AID-HEC276〉3.0.CO;2-B [pii]. (Pubitemid 27384646)
25. Gardiner JC, Luo Z, Roman LA (2009) Fixed effects, random effects and GEE: what are the differences? Stat Med 28: 221-239. 10.1002/sim.3478 [doi].
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 130: 461-470. 199903160-00002 [pii].
27. O'Callaghan CA, Shine B, Lasserson DS (2011) Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open 1: e000308. bmjopen-2011-000308 [pii];10.1136/bmjopen-2011-000308 [doi].
28. Office for National Statistics (2012) All releases of Population Estimates for UK, England and Wales, Scotland and Northern Ireland.
29. Gifford FJ, Methven S, Boag DE, Spalding EM, MacGregor MS (2011) Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae. QJM 104: 1045-1053.
30. Glynn LG, Anderson J, Reddan D, Murphy AW (2009) Chronic kidney disease in general practice: prevalence, diagnosis, and standards of care. Ir Med J 102: 285-288.
31. Carter JL, Stevens PE, Irving JE, Lamb EJ (2011) Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age. QJM 104: 839-847.
32. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, et al (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17: 2275-2284. ASN.2005121273 [pii] 10.1681/ASN.2005121273.
33. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, et al (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188. 10.1681/ASN.2004070539. (Pubitemid 43073171)
34. O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, et al (2006) Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17: 846-853. ASN.2005090986 [pii] 10.1681/ASN.2005090986.
35. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL (1978) Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 299: 741-744. 10.1056/NEJM197810052991403 [doi]. (Pubitemid 9040909)
36. Johnston ME, Gibson ES, Terry CW, Haynes RB, Taylor DW, et al (1984) Effects of labelling on income, work and social function among hypertensive employees. J Chronic Dis 37: 417-423. (Pubitemid 14147845)
37. Walker N, Bankart J, Brunskill N, Baker R (2011) Which factors are associated with higher rates of chronic kidney disease recording in primary care? A cross-sectional survey of GP practices. Br J Gen Pract 61: 203-205. 10.3399/bjgp11X561212 [doi].